Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 457 to 465 of 465 entries
Sorted by: Best Match Show Resources per page
ASPECTS Interobserver Agreement of 100 Investigators from the TENSION Study.

Clinical neuroradiology

van Horn N, Kniep H, Broocks G, Meyer L, Flottmann F, Bechstein M, Götz J, Thomalla G, Bendszus M, Bonekamp S, Pfaff JAR, Dellani PR, Fiehler J, Hanning U.
PMID: 33502563
Clin Neuroradiol. 2021 Dec;31(4):1093-1100. doi: 10.1007/s00062-020-00988-x. Epub 2021 Jan 27.

PURPOSE: Evaluating the extent of cerebral ischemic infarction is essential for treatment decisions and assessment of possible complications in patients with acute ischemic stroke. Patients are often triaged according to image-based early signs of infarction, defined by Alberta Stroke...

Cite
van Horn N, Kniep H, Broocks G, et al. ASPECTS Interobserver Agreement of 100 Investigators from the TENSION Study. Clin Neuroradiol. 2021;31(4):1093-1100doi: 10.1007/s00062-020-00988-x.
van Horn, N., Kniep, H., Broocks, G., Meyer, L., Flottmann, F., Bechstein, M., Götz, J., Thomalla, G., Bendszus, M., Bonekamp, S., Pfaff, J. A. R., Dellani, P. R., Fiehler, J., & Hanning, U. (2021). ASPECTS Interobserver Agreement of 100 Investigators from the TENSION Study. Clinical neuroradiology, 31(4), 1093-1100. https://doi.org/10.1007/s00062-020-00988-x
van Horn, Noel, et al. "ASPECTS Interobserver Agreement of 100 Investigators from the TENSION Study." Clinical neuroradiology vol. 31,4 (2021): 1093-1100. doi: https://doi.org/10.1007/s00062-020-00988-x
van Horn N, Kniep H, Broocks G, Meyer L, Flottmann F, Bechstein M, Götz J, Thomalla G, Bendszus M, Bonekamp S, Pfaff JAR, Dellani PR, Fiehler J, Hanning U. ASPECTS Interobserver Agreement of 100 Investigators from the TENSION Study. Clin Neuroradiol. 2021 Dec;31(4):1093-1100. doi: 10.1007/s00062-020-00988-x. Epub 2021 Jan 27. PMID: 33502563; PMCID: PMC8648648.
Copy Download .nbib Format: NLM
Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis.

Molecular neurobiology

Tremolanti C, Cavallini C, Meyer L, Klein C, Da Pozzo E, Costa B, Germelli L, Taliani S, Patte-Mensah C, Mensah-Nyagan AG.
PMID: 35018577
Mol Neurobiol. 2022 Jan 11; doi: 10.1007/s12035-022-02737-2. Epub 2022 Jan 11.

Multiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system (CNS) caused by CNS infiltration of peripheral immune cells, immune-mediated attack of the myelin sheath, neuroinflammation, and/or axonal/neuronal dysfunctions. Some drugs are available to cope...

Cite
Tremolanti C, Cavallini C, Meyer L, et al. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis. Mol Neurobiol. 2022;doi: 10.1007/s12035-022-02737-2.
Tremolanti, C., Cavallini, C., Meyer, L., Klein, C., Da Pozzo, E., Costa, B., Germelli, L., Taliani, S., Patte-Mensah, C., & Mensah-Nyagan, A. G. (2022). Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis. Molecular neurobiology, . https://doi.org/10.1007/s12035-022-02737-2
Tremolanti, Chiara, et al. "Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis." Molecular neurobiology vol. (2022). doi: https://doi.org/10.1007/s12035-022-02737-2
Tremolanti C, Cavallini C, Meyer L, Klein C, Da Pozzo E, Costa B, Germelli L, Taliani S, Patte-Mensah C, Mensah-Nyagan AG. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis. Mol Neurobiol. 2022 Jan 11; doi: 10.1007/s12035-022-02737-2. Epub 2022 Jan 11. PMID: 35018577.
Copy Download .nbib Format: NLM
Paradoxical cognitive trajectories in men from earlier to later adulthood.

Neurobiology of aging

Eglit GML, Elman JA, Panizzon MS, Sanderson-Cimino M, Williams ME, Dale AM, Eyler LT, Fennema-Notestine C, Gillespie NA, Gustavson DE, Hatton SN, Hagler DJ, Hauger RL, Jak AJ, Logue MW, McEvoy LK, McKenzie RE, Neale MC, Puckett O, Reynolds CA, Toomey R, Tu XM, Whitsel N, Xian H, Lyons MJ, Franz CE, Kremen WS.
PMID: 34785406
Neurobiol Aging. 2022 Jan;109:229-238. doi: 10.1016/j.neurobiolaging.2021.10.002. Epub 2021 Oct 14.

Because longitudinal studies of aging typically lack cognitive data from earlier ages, it is unclear how general cognitive ability (GCA) changes throughout the life course. In 1173 Vietnam Era Twin Study of Aging (VETSA) participants, we assessed young adult...

Cite
Eglit GML, Elman JA, Panizzon MS, et al. Paradoxical cognitive trajectories in men from earlier to later adulthood. Neurobiol Aging. 2021;109:229-238doi: 10.1016/j.neurobiolaging.2021.10.002.
Eglit, G. M. L., Elman, J. A., Panizzon, M. S., Sanderson-Cimino, M., Williams, M. E., Dale, A. M., Eyler, L. T., Fennema-Notestine, C., Gillespie, N. A., Gustavson, D. E., Hatton, S. N., Hagler, D. J., Hauger, R. L., Jak, A. J., Logue, M. W., McEvoy, L. K., McKenzie, R. E., Neale, M. C., Puckett, O., Reynolds, C. A., Toomey, R., Tu, X. M., Whitsel, N., Xian, H., Lyons, M. J., Franz, C. E., & Kremen, W. S. (2022). Paradoxical cognitive trajectories in men from earlier to later adulthood. Neurobiology of aging, 109229-238. https://doi.org/10.1016/j.neurobiolaging.2021.10.002
Eglit, Graham M L, et al. "Paradoxical cognitive trajectories in men from earlier to later adulthood." Neurobiology of aging vol. 109 (2022): 229-238. doi: https://doi.org/10.1016/j.neurobiolaging.2021.10.002
Eglit GML, Elman JA, Panizzon MS, Sanderson-Cimino M, Williams ME, Dale AM, Eyler LT, Fennema-Notestine C, Gillespie NA, Gustavson DE, Hatton SN, Hagler DJ, Hauger RL, Jak AJ, Logue MW, McEvoy LK, McKenzie RE, Neale MC, Puckett O, Reynolds CA, Toomey R, Tu XM, Whitsel N, Xian H, Lyons MJ, Franz CE, Kremen WS. Paradoxical cognitive trajectories in men from earlier to later adulthood. Neurobiol Aging. 2022 Jan;109:229-238. doi: 10.1016/j.neurobiolaging.2021.10.002. Epub 2021 Oct 14. PMID: 34785406; PMCID: PMC8715388.
Copy Download .nbib Format: NLM
Insecticidal efficacy against Phlebotomus perniciosus in dogs treated orally with fluralaner in two different parallel-group, negative-control, random and masked trials.

Parasites & vectors

Bongiorno G, Meyer L, Evans A, Lekouch N, Doherty P, Chiummo R, Gradoni L.
PMID: 34998427
Parasit Vectors. 2022 Jan 08;15(1):18. doi: 10.1186/s13071-021-05128-z.

BACKGROUND: Dogs are the reservoir host of Leishmania infantum, the agent of zoonotic visceral leishmaniasis (VL), which is transmitted by the bite of phlebotomine sand flies. The sand fly Phlebotomus perniciosus is the main vector of zoonotic VL in...

Cite
Bongiorno G, Meyer L, Evans A, et al. Insecticidal efficacy against Phlebotomus perniciosus in dogs treated orally with fluralaner in two different parallel-group, negative-control, random and masked trials. Parasit Vectors. 2022;15(1):18doi: 10.1186/s13071-021-05128-z.
Bongiorno, G., Meyer, L., Evans, A., Lekouch, N., Doherty, P., Chiummo, R., & Gradoni, L. (2022). Insecticidal efficacy against Phlebotomus perniciosus in dogs treated orally with fluralaner in two different parallel-group, negative-control, random and masked trials. Parasites & vectors, 15(1), 18. https://doi.org/10.1186/s13071-021-05128-z
Bongiorno, Gioia, et al. "Insecticidal efficacy against Phlebotomus perniciosus in dogs treated orally with fluralaner in two different parallel-group, negative-control, random and masked trials." Parasites & vectors vol. 15,1 (2022): 18. doi: https://doi.org/10.1186/s13071-021-05128-z
Bongiorno G, Meyer L, Evans A, Lekouch N, Doherty P, Chiummo R, Gradoni L. Insecticidal efficacy against Phlebotomus perniciosus in dogs treated orally with fluralaner in two different parallel-group, negative-control, random and masked trials. Parasit Vectors. 2022 Jan 08;15(1):18. doi: 10.1186/s13071-021-05128-z. PMID: 34998427; PMCID: PMC8742344.
Copy Download .nbib Format: NLM
Successional Stages in Infant Gut Microbiota Maturation.

mBio

Beller L, Deboutte W, Falony G, Vieira-Silva S, Tito RY, Valles-Colomer M, Rymenans L, Jansen D, Van Espen L, Papadaki MI, Shi C, Yinda CK, Zeller M, Faust K, Van Ranst M, Raes J, Matthijnssens J.
PMID: 34903050
mBio. 2021 Dec 14;e0185721. doi: 10.1128/mBio.01857-21. Epub 2021 Dec 14.

Disturbances in the primary colonization of the infant gut can result in lifelong consequences and have been associated with a range of host conditions. Although early-life factors have been shown to affect infant gut microbiota development, our current understanding...

Cite
Beller L, Deboutte W, Falony G, et al. Successional Stages in Infant Gut Microbiota Maturation. mBio. 2021;e0185721doi: 10.1128/mBio.01857-21.
Beller, L., Deboutte, W., Falony, G., Vieira-Silva, S., Tito, R. Y., Valles-Colomer, M., Rymenans, L., Jansen, D., Van Espen, L., Papadaki, M. I., Shi, C., Yinda, C. K., Zeller, M., Faust, K., Van Ranst, M., Raes, J., & Matthijnssens, J. (2021). Successional Stages in Infant Gut Microbiota Maturation. mBio, e0185721. https://doi.org/10.1128/mBio.01857-21
Beller, Leen, et al. "Successional Stages in Infant Gut Microbiota Maturation." mBio vol. (2021): e0185721. doi: https://doi.org/10.1128/mBio.01857-21
Beller L, Deboutte W, Falony G, Vieira-Silva S, Tito RY, Valles-Colomer M, Rymenans L, Jansen D, Van Espen L, Papadaki MI, Shi C, Yinda CK, Zeller M, Faust K, Van Ranst M, Raes J, Matthijnssens J. Successional Stages in Infant Gut Microbiota Maturation. mBio. 2021 Dec 14;e0185721. doi: 10.1128/mBio.01857-21. Epub 2021 Dec 14. PMID: 34903050.
Copy Download .nbib Format: NLM
Emission, Transport, and Deposition of visible Plastics in an Estuary and the Baltic Sea-a Monitoring and Modeling Approach.

Environmental management

Schernewski G, Radtke H, Robbe E, Haseler M, Hauk R, Meyer L, Piehl S, Riedel J, Labrenz M.
PMID: 34505927
Environ Manage. 2021 Dec;68(6):860-881. doi: 10.1007/s00267-021-01534-2. Epub 2021 Sep 10.

AIM: was to assess whether a comprehensive approach linking existing knowledge with monitoring and modeling can provide an improved insight into coastal and marine plastics pollution. We focused on large micro- and mesoplastic (1-25 mm) and selected macroplastic items....

Cite
Schernewski G, Radtke H, Robbe E, et al. Emission, Transport, and Deposition of visible Plastics in an Estuary and the Baltic Sea-a Monitoring and Modeling Approach. Environ Manage. 2021;68(6):860-881doi: 10.1007/s00267-021-01534-2.
Schernewski, G., Radtke, H., Robbe, E., Haseler, M., Hauk, R., Meyer, L., Piehl, S., Riedel, J., & Labrenz, M. (2021). Emission, Transport, and Deposition of visible Plastics in an Estuary and the Baltic Sea-a Monitoring and Modeling Approach. Environmental management, 68(6), 860-881. https://doi.org/10.1007/s00267-021-01534-2
Schernewski, Gerald, et al. "Emission, Transport, and Deposition of visible Plastics in an Estuary and the Baltic Sea-a Monitoring and Modeling Approach." Environmental management vol. 68,6 (2021): 860-881. doi: https://doi.org/10.1007/s00267-021-01534-2
Schernewski G, Radtke H, Robbe E, Haseler M, Hauk R, Meyer L, Piehl S, Riedel J, Labrenz M. Emission, Transport, and Deposition of visible Plastics in an Estuary and the Baltic Sea-a Monitoring and Modeling Approach. Environ Manage. 2021 Dec;68(6):860-881. doi: 10.1007/s00267-021-01534-2. Epub 2021 Sep 10. PMID: 34505927; PMCID: PMC8578054.
Copy Download .nbib Format: NLM
Lifestyle and the aging brain: interactive effects of modifiable lifestyle behaviors and cognitive ability in men from midlife to old age.

Neurobiology of aging

Franz CE, Hatton SN, Elman JA, Warren T, Gillespie NA, Whitsel NA, Puckett OK, Dale AM, Eyler LT, Fennema-Notestine C, Hagler DJ, Hauger RL, McKenzie R, Neale MC, Panizzon MS, Pearce RC, Reynolds CA, Sanderson-Cimino M, Toomey R, Tu XM, Williams M, Xian H, Lyons MJ, Kremen WS.
PMID: 34547718
Neurobiol Aging. 2021 Dec;108:80-89. doi: 10.1016/j.neurobiolaging.2021.08.007. Epub 2021 Aug 19.

We examined the influence of lifestyle on brain aging after nearly 30 years, and tested the hypothesis that young adult general cognitive ability (GCA) would moderate these effects. In the community-dwelling Vietnam Era Twin Study of Aging (VETSA), 431...

Cite
Franz CE, Hatton SN, Elman JA, et al. Lifestyle and the aging brain: interactive effects of modifiable lifestyle behaviors and cognitive ability in men from midlife to old age. Neurobiol Aging. 2021;108:80-89doi: 10.1016/j.neurobiolaging.2021.08.007.
Franz, C. E., Hatton, S. N., Elman, J. A., Warren, T., Gillespie, N. A., Whitsel, N. A., Puckett, O. K., Dale, A. M., Eyler, L. T., Fennema-Notestine, C., Hagler, D. J., Hauger, R. L., McKenzie, R., Neale, M. C., Panizzon, M. S., Pearce, R. C., Reynolds, C. A., Sanderson-Cimino, M., Toomey, R., Tu, X. M., Williams, M., Xian, H., Lyons, M. J., & Kremen, W. S. (2021). Lifestyle and the aging brain: interactive effects of modifiable lifestyle behaviors and cognitive ability in men from midlife to old age. Neurobiology of aging, 10880-89. https://doi.org/10.1016/j.neurobiolaging.2021.08.007
Franz, Carol E, et al. "Lifestyle and the aging brain: interactive effects of modifiable lifestyle behaviors and cognitive ability in men from midlife to old age." Neurobiology of aging vol. 108 (2021): 80-89. doi: https://doi.org/10.1016/j.neurobiolaging.2021.08.007
Franz CE, Hatton SN, Elman JA, Warren T, Gillespie NA, Whitsel NA, Puckett OK, Dale AM, Eyler LT, Fennema-Notestine C, Hagler DJ, Hauger RL, McKenzie R, Neale MC, Panizzon MS, Pearce RC, Reynolds CA, Sanderson-Cimino M, Toomey R, Tu XM, Williams M, Xian H, Lyons MJ, Kremen WS. Lifestyle and the aging brain: interactive effects of modifiable lifestyle behaviors and cognitive ability in men from midlife to old age. Neurobiol Aging. 2021 Dec;108:80-89. doi: 10.1016/j.neurobiolaging.2021.08.007. Epub 2021 Aug 19. PMID: 34547718.
Copy Download .nbib Format: NLM
128 days of SARS-CoV-2 viral shedding in a haemodialysis patient.

Clinical kidney journal

Heylen L, Oris E, Wollants E, Maes P, Van Kerrebroeck M, Peeters J, Steensels D.
PMID: 33841874
Clin Kidney J. 2021 Jan 24;14(4):1284-1286. doi: 10.1093/ckj/sfab004. eCollection 2021 Apr.

No abstract available.

Cite
Heylen L, Oris E, Wollants E, et al. 128 days of SARS-CoV-2 viral shedding in a haemodialysis patient. Clin Kidney J. 2021;14(4):1284-1286doi: 10.1093/ckj/sfab004.
Heylen, L., Oris, E., Wollants, E., Maes, P., Van Kerrebroeck, M., Peeters, J., & Steensels, D. (2021). 128 days of SARS-CoV-2 viral shedding in a haemodialysis patient. Clinical kidney journal, 14(4), 1284-1286. https://doi.org/10.1093/ckj/sfab004
Heylen, Line, et al. "128 days of SARS-CoV-2 viral shedding in a haemodialysis patient." Clinical kidney journal vol. 14,4 (2021): 1284-1286. doi: https://doi.org/10.1093/ckj/sfab004
Heylen L, Oris E, Wollants E, Maes P, Van Kerrebroeck M, Peeters J, Steensels D. 128 days of SARS-CoV-2 viral shedding in a haemodialysis patient. Clin Kidney J. 2021 Jan 24;14(4):1284-1286. doi: 10.1093/ckj/sfab004. eCollection 2021 Apr. PMID: 33841874; PMCID: PMC7928996.
Copy Download .nbib Format: NLM
Persistent challenges in endovascular treatment decision-making for acute ischaemic stroke.

Current opinion in neurology

Fiehler J, Nawka MT, Meyer L.
PMID: 34812746
Curr Opin Neurol. 2022 Feb 01;35(1):18-23. doi: 10.1097/WCO.0000000000001006.

PURPOSE OF REVIEW: Although endovascular treatment (EVT) is the gold standard for treating acute stroke patients with large vessel occlusion (LVO), multiple challenges in decision-making for specific conditions persist. Recent evidence on a selection of patient subgroups will be...

Cite
Fiehler J, Nawka MT, Meyer L. Persistent challenges in endovascular treatment decision-making for acute ischaemic stroke. Curr Opin Neurol. 2022;35(1):18-23doi: 10.1097/WCO.0000000000001006.
Fiehler, J., Nawka, M. T., & Meyer, L. (2022). Persistent challenges in endovascular treatment decision-making for acute ischaemic stroke. Current opinion in neurology, 35(1), 18-23. https://doi.org/10.1097/WCO.0000000000001006
Fiehler, Jens, et al. "Persistent challenges in endovascular treatment decision-making for acute ischaemic stroke." Current opinion in neurology vol. 35,1 (2022): 18-23. doi: https://doi.org/10.1097/WCO.0000000000001006
Fiehler J, Nawka MT, Meyer L. Persistent challenges in endovascular treatment decision-making for acute ischaemic stroke. Curr Opin Neurol. 2022 Feb 01;35(1):18-23. doi: 10.1097/WCO.0000000000001006. PMID: 34812746.
Copy Download .nbib Format: NLM
Showing 457 to 465 of 465 entries